CliffBio
small molecule

HYCODAN

HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE

Loss of exclusivity—loss of exclusivity
CompanyGenus Lifesciences Inc. →See this company's full patent-cliff portfolio

Drug detail

Brand nameHYCODAN
Active ingredientHOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE
Strength1.5MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalJuly 1988
Marketing statusRX

More from Genus Lifesciences Inc.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

HYCODAN patent cliff — loss of exclusivity — | CliffBio